Cellectar Biosciences (CLRB) Earnings Date, Estimates & Call Transcripts → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free CLRB Stock Alerts $3.33 -0.03 (-0.89%) (As of 05/16/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (Mar. 27) -$0.66 Missed By -$0.07 Consensus EPS (Mar. 27) -$0.59 Get Cellectar Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for CLRB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCLRB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLRB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Cellectar Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.37)($0.37)($0.37)Q3 20241($0.38)($0.38)($0.38)Q4 20241($0.42)($0.42)($0.42)CLRB Earnings Date and InformationCellectar Biosciences last posted its quarterly earnings data on March 27th, 2024. The biopharmaceutical company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.07. Cellectar Biosciences has generated ($3.10) earnings per share over the last year (($3.10) diluted earnings per share). Earnings for Cellectar Biosciences are expected to grow in the coming year, from ($1.85) to ($0.58) per share. Cellectar Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Cellectar Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024Estimated)------- 3/27/2024Q4 2023($0.59)($0.66)($0.07)($0.92)--11/13/2023Q3 2023($0.44)($0.82)($0.38)($0.43)--8/14/2023Q2 2023($0.69)($0.73)($0.04)($0.73)--5/4/2023Q1 2023($0.75)($0.76)($0.01)($0.76)--3/9/2023Q4 2022($0.83)($0.55)+$0.28($0.55)--11/3/2022Q3 2022($1.21)($1.28)($0.07)($1.28)-- Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/5/2022Q2 2022($1.08)($1.22)($0.14)($1.22)--5/10/2022Q1 2022($1.10)($1.00)+$0.10($0.10)-- 3/21/2022Q4 2021($1.00)($1.00)-($0.10)--11/7/2021Q3 2021($1.10)($1.00)+$0.10($0.10)--8/8/2021Q2 2021($1.10)($1.10)-($0.11)-- Cellectar Biosciences Earnings - Frequently Asked Questions When is Cellectar Biosciences's earnings date? Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on CLRB's earnings history. Did Cellectar Biosciences beat their earnings estimates last quarter? In the previous quarter, Cellectar Biosciences (NASDAQ:CLRB) missed the analysts' consensus estimate of ($0.59) by $0.07 with a reported earnings per share (EPS) of ($0.66). Learn more on analysts' earnings estimate vs. CLRB's actual earnings. How much profit does Cellectar Biosciences generate each year? Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$37.98 million. CLRB has generated -$3.10 earnings per share over the last four quarters. What is Cellectar Biosciences's EPS forecast for next year? Cellectar Biosciences's earnings are expected to grow from ($1.85) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies: OptiNose Earnings Date Societal CDMO Earnings Date Rezolute Earnings Date Relmada Therapeutics Earnings Date Coya Therapeutics Earnings Date PMV Pharmaceuticals Earnings Date Cartesian Therapeutics Earnings Date Immunic Earnings Date Abeona Therapeutics Earnings Date Vistagen Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:CLRB) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.